Insulet Total Current Assets 2010-2025 | PODD
Insulet total current assets from 2010 to 2025. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
- Insulet total current assets for the quarter ending March 31, 2025 were $2.328B, a 43.87% increase year-over-year.
- Insulet total current assets for 2024 were $1.891B, a 19.48% increase from 2023.
- Insulet total current assets for 2023 were $1.583B, a 20.46% increase from 2022.
- Insulet total current assets for 2022 were $1.314B, a 1.19% decline from 2021.
| Insulet Annual Total Current Assets (Millions of US $) |
|
|---|---|
| 2024 | $1,891 |
| 2023 | $1,583 |
| 2022 | $1,314 |
| 2021 | $1,330 |
| 2020 | $1,249 |
| 2019 | $591 |
| 2018 | $461 |
| 2017 | $537 |
| 2016 | $370 |
| 2015 | $191 |
| 2014 | $208 |
| 2013 | $198 |
| 2012 | $110 |
| 2011 | $133 |
| 2010 | $142 |
| 2009 | $154 |
| Insulet Quarterly Total Current Assets (Millions of US $) |
|
|---|---|
| 2025-03-31 | $2,328 |
| 2024-12-31 | $1,891 |
| 2024-09-30 | $1,861 |
| 2024-06-30 | $1,749 |
| 2024-03-31 | $1,618 |
| 2023-12-31 | $1,583 |
| 2023-09-30 | $1,471 |
| 2023-06-30 | $1,422 |
| 2023-03-31 | $1,330 |
| 2022-12-31 | $1,314 |
| 2022-09-30 | $1,329 |
| 2022-06-30 | $1,309 |
| 2022-03-31 | $1,285 |
| 2021-12-31 | $1,330 |
| 2021-09-30 | $1,307 |
| 2021-06-30 | $1,253 |
| 2021-03-31 | $1,192 |
| 2020-12-31 | $1,249 |
| 2020-09-30 | $1,160 |
| 2020-06-30 | $1,086 |
| 2020-03-31 | $541 |
| 2019-12-31 | $591 |
| 2019-09-30 | $794 |
| 2019-06-30 | $499 |
| 2019-03-31 | $496 |
| 2018-12-31 | $461 |
| 2018-09-30 | $446 |
| 2018-06-30 | $422 |
| 2018-03-31 | $452 |
| 2017-12-31 | $537 |
| 2017-09-30 | $366 |
| 2017-06-30 | $339 |
| 2017-03-31 | $337 |
| 2016-12-31 | $370 |
| 2016-09-30 | $362 |
| 2016-06-30 | $181 |
| 2016-03-31 | $172 |
| 2015-12-31 | $191 |
| 2015-09-30 | $194 |
| 2015-06-30 | $204 |
| 2015-03-31 | $205 |
| 2014-12-31 | $208 |
| 2014-09-30 | $207 |
| 2014-06-30 | $232 |
| 2014-03-31 | $200 |
| 2013-12-31 | $198 |
| 2013-09-30 | $200 |
| 2013-06-30 | $197 |
| 2013-03-31 | $195 |
| 2012-12-31 | $110 |
| 2012-09-30 | $114 |
| 2012-06-30 | $116 |
| 2012-03-31 | $128 |
| 2011-12-31 | $133 |
| 2011-09-30 | $138 |
| 2011-06-30 | $148 |
| 2011-03-31 | $134 |
| 2010-12-31 | $142 |
| 2010-09-30 | $133 |
| 2010-06-30 | $146 |
| 2010-03-31 | $142 |
| 2009-12-31 | $154 |
| 2009-09-30 | $100 |
| 2009-06-30 | $80 |
| 2009-03-31 | $100 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $21.238B | $2.072B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.372B | 27.70 |
| Boston Scientific (BSX) | United States | $149.971B | 37.54 |
| Stryker (SYK) | United States | $142.469B | 29.79 |
| EssilorLuxottica (ESLOY) | France | $128.310B | 0.00 |
| Medtronic (MDT) | Ireland | $109.952B | 15.59 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.265B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.015B | 26.80 |
| ResMed (RMD) | United States | $36.786B | 27.63 |
| GE HealthCare Technologies (GEHC) | United States | $32.917B | 15.63 |
| Agilent Technologies (A) | United States | $32.815B | 21.39 |
| Terumo (TRUMY) | Japan | $26.606B | 34.56 |
| Koninklijke Philips (PHG) | Netherlands | $21.242B | 14.90 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.915B | 11.51 |
| Baxter (BAX) | United States | $15.293B | 11.42 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.517B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.087B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.313B | 21.97 |
| Lantheus Holdings (LNTH) | United States | $5.465B | 13.78 |
| Prestige Consumer Healthcare (PBH) | United States | $4.133B | 18.46 |
| Perrigo (PRGO) | Ireland | $3.618B | 9.17 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.366B | 15.33 |
| ICU Medical (ICUI) | United States | $3.165B | 23.34 |
| Envista Holdings (NVST) | United States | $3.154B | 26.21 |
| GN Store Nord (GNNDY) | Denmark | $2.272B | 18.82 |
| QuidelOrtho (QDEL) | United States | $1.916B | 13.18 |
| LeMaitre Vascular (LMAT) | United States | $1.846B | 41.26 |
| AtriCure (ATRC) | United States | $1.565B | 0.00 |
| Acuren (TIC) | United States | $1.335B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.144B | 11.62 |
| Neogen (NEOG) | United States | $1.083B | 13.86 |
| Green Thumb Industries (GTBIF) | United States | $1.059B | 23.81 |
| BioLife Solutions (BLFS) | United States | $1.022B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.971B | 12.41 |
| InMode (INMD) | Israel | $0.843B | 8.50 |
| Kestra Medical Technologies (KMTS) | United States | $0.796B | 0.00 |
| CeriBell (CBLL) | United States | $0.643B | 0.00 |
| Evolus (EOLS) | United States | $0.600B | 0.00 |
| Owens & Minor (OMI) | United States | $0.576B | 4.78 |
| Curaleaf Holdings (CURLF) | Canada | $0.547B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.545B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.512B | 0.00 |
| Valneva SE (VALN) | France | $0.487B | 0.00 |
| Surmodics (SRDX) | United States | $0.417B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.386B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.316B | 11.62 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.307B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.282B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.263B | 78.00 |
| Viemed Healthcare (VMD) | United States | $0.260B | 21.93 |
| Cerus (CERS) | United States | $0.256B | 0.00 |
| Quanterix (QTRX) | United States | $0.248B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.245B | 0.00 |
| ZimVie (ZIMV) | United States | $0.240B | 10.90 |
| Canopy Growth (CGC) | Canada | $0.237B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.236B | 0.00 |
| Biote (BTMD) | United States | $0.218B | 6.14 |
| OraSure Technologies (OSUR) | United States | $0.215B | 0.00 |
| Brainsway (BWAY) | Israel | $0.208B | 55.15 |
| TriSalus Life Sciences (TLSI) | United States | $0.204B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.192B | 0.00 |
| Omeros (OMER) | United States | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.178B | 0.00 |
| Organigram Global (OGI) | Canada | $0.177B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.174B | 14.20 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 15.76 |
| Jin Medical (ZJYL) | China | $0.110B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Fonar (FONR) | United States | $0.087B | 11.25 |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| Agape ATP (ATPC) | $0.076B | 0.00 | |
| Zynex (ZYXI) | United States | $0.073B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Apyx Medical (APYX) | United States | $0.065B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| Nephros (NEPH) | United States | $0.038B | 51.14 |
| United-Guardian (UG) | United States | $0.038B | 12.98 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.017B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.013B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |